Executive Vice President and Chief Commercial Officer · CorMedix Inc. (CRMD)

Erin Mistry

FY2023 is the first fiscal year CompBrief holds for Erin Mistry as a named executive officer of CorMedix; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$1,240,577

Salary $389,577Stock awards $0

3rd of 4 named executive officers at CorMedix by FY2023 total.

4 named officers on file for CorMedix, FY2023

Erin Mistry’s pay file — $29

  • 1 fiscal year of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how CorMedix’s whole pay program stands against its peers

  • CorMedix’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on CRMD→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed October 8, 2024 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Erin Mistry’s full pay file as a PDF — free

More than this page: up to 10 years of Erin’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Erin Mistry compensation by year

CorMedix Summary Compensation Table · the one fiscal year held
In US dollars, as CorMedix reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2023
Salary$389,577
Bonus$0
Stock awards$0
Option awards$694,200
Non-equity incentive$156,800
Pension and deferred compensation$0
All other$0
Total$1,240,577

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: CorMedix Inc. DEF 14A filed October 8, 2024, accession 0001213900-24-086301, and prior-year filings. Open the filing on EDGAR.

How this page was built: the CorMedix Inc. filed document, accession 0001213900-24-086301. Every figure is read from that document and cited to the page and table it appears in. Filed October 8, 2024.

Equity holdings

unvested awards at FY2023 year-end
TypeUnvested unitsValue at year-endExercise price
Option2,500—$3.57
Option10,500—$4.03
Option2,500—$8.32
Option60,000—$5.45
Option150,000—$4.43

Per the Outstanding Equity Awards at Fiscal Year-End table in CorMedix Inc.'s FY2023 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

4 Form 4 lines since the FY2023 proxy (filed October 8, 2024)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2025-01-10Tax withholding—5,689$11.19100,992
2025-01-02Grant or award—62,500$0.00114,511
2025-01-02Tax withholding—7,830$8.22106,681
2024-10-31Purchase—1,500$9.9952,011

The 4 most recent of 4 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

CorMedix’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
Joseph TodiscoChief Executive Officer$2,459,342
Phoebe MountsFormer Executive Vice President and General Counsel and Head of Regulatory, Compliance and Legal$1,254,582
Erin Mistry · this pageExecutive Vice President and Chief Commercial Officer$1,240,577
Matthew DavidChief Financial Officer$1,031,150

The full CorMedix compensation record

free company brief

This page is one person within CorMedix's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are CorMedix's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Erin Mistry's compensation dossier · One-time report. No refunds.